Carrie A. Sims, MD, PhD; Daniel Holena, MD; Patrick Kim, MD; et al.
free access
has audio
JAMA Surg. 2019;154(11):994-1003. doi:10.1001/jamasurg.2019.2884
This randomized clinical trial assesses whether low-dose supplementation of arginine vasopressin during the resuscitation of hemorrhagic shock decreases the need for transfusions in patients with trauma.
-
Podcast:
Arginine Vasopressin Supplementation in Early Traumatic Shock
Kyle H. Sheetz, MD, MSc; Karan R. Chhabra, MD; Margaret E. Smith, MD; et al.
free access
JAMA Surg. 2019;154(11):1005-1012. doi:10.1001/jamasurg.2019.3017
This longitudinal cohort study evaluated Medicare claims of 516 392 patients who underwent high-risk cancer surgery from 2005 through 2016 to determine trends in 30-day mortality and postoperative complications in hospitals that met the Leapfrog volume standards vs those that did not meet the standards.
-
Invited Commentary
Volume Standards for High-risk Cancer Surgery
Yuman Fong, MD; Marco G. Patti, MD
JAMA Surg
J. Madison Hyer, MS; Aslam Ejaz, MD, MPH; Diamantis I. Tsilimigras, MD; et al.
free access
JAMA Surg. 2019;154(11):1014-1021. doi:10.1001/jamasurg.2019.2979
In this cohort study, health care expenditures among patients in the year preceding and following elective surgery are evaluated with a machine learning approach to identify clinical and comorbid patterns that may be associated with an increased risk of health care super-utilization in the year following surgery.
-
Invited Commentary
Surgical Hot Spotting: Who Becomes a Super-Utilizer After Surgery?
Karan R. Chhabra, MD, MSc; Amir A. Ghaferi, MD, MS; Hari Nathan, MD, PhD
JAMA Surg
Kelsey Gray, MD; Angela Neville, MD; Amy H. Kaji, MD, PhD; et al.
free access
JAMA Surg. 2019;154(11):1023-1029. doi:10.1001/jamasurg.2019.2879
This survey-based study explores whether differences exist between the perspectives of male and female general surgery residents on future career goals, salary expectations, and salary negotiation that may contribute to disparity later in their careers.
Zhen-Yu Wu, MD; Hee-Jeong Kim, MD, PhD; Jong-Won Lee, MD, PhD; et al.
free access
JAMA Surg. 2019;154(11):1030-1037. doi:10.1001/jamasurg.2019.2959
This cohort study assesses the incidence of and risk factors and outcomes associated with breast cancer recurrence of the nipple-areola complex among patients with invasive breast cancer who underwent nipple-sparing mastectomy and immediate breast reconstruction.
Robert P. Jones, PhD; Eftychia-Eirini Psarelli, MSc; Richard Jackson, PhD; et al.
free access
JAMA Surg. 2019;154(11):1038-1048. doi:10.1001/jamasurg.2019.3337
This secondary analysis of a randomized clinical trial investigates patterns of recurrence after adjuvant chemotherapy in pancreatic cancer and the association with survival.
-
Invited Commentary
Pancreatic Ductal Adenocarcinoma—ESPAC…or It’s Back?
Maxwell Trudeau, BS; Charles M. Vollmer Jr, MD
JAMA Surg
Christopher E. Louie, MB, MPH; Julia L. Kelly, MS; Richard J. Barth Jr, MD
free access
JAMA Surg. 2019;154(11):1049-1054. doi:10.1001/jamasurg.2019.2875
This study investigates whether decreased opioid prescribing is associated with a decrease in patient-reported satisfaction with their surgeon.
Jennifer M. Siu, MD, MPH; Justin C. McCarty, DO, MPH; Shekhar Gadkaree, MD; et al.
free access
online only
JAMA Surg. 2019;154(11):e193146. doi:10.1001/jamasurg.2019.3146
This cohort study examines the association of vessel-sealant devices compared with conventional hemostasis in thyroid operations with the development of neck hematoma.
-
Invited Commentary
Implementation of Vessel-Sealing Devices in Thyroid Surgery
Sophie Dream, MD; Tracy S. Wang, MD, MPH
JAMA Surg
Stephanie Tung, MD; Laura E. Davis, MSc; Julie Hallet, MD; et al.
free access
online only
JAMA Surg. 2019;154(11):e193348. doi:10.1001/jamasurg.2019.3348
This cohort study describes symptom burdens in Canadian patients with pancreatic adenocarcinoma who underwent resection.